Spinnaker Opports - Update on Medicinal Cannabis RTO
("Spinnaker" or the "Company")
Update on Medicinal Cannabis RTO
Further to the update provided on
Kanabo and the Company continue to make good progress towards satisfaction of the conditions for completion of the Proposed Acquisition as set out in the previous update. However, until all conditions are satisfied, there can be no certainty that the transaction will proceed.
The full terms of the Proposed Acquisition are expected to be set out in a prospectus which will be published in due course.
"We are pleased to receive this additional financial support from Spinnaker which enables Kanabo to keep working at full speed to deliver its strategy while we await completion of the transaction."
"Along with Kanabo, we very much look forward to bringing this compelling business to the
For further information, please visit http://www.spinnakeropportunities.uk/ or contact the following:
Tel: +44 (0)20 7469 0930
Tel: +44 (0)1483 413 500 / +44 (0) 203 871 4038
Blytheweigh (Financial PR)
Tel: +44 (0) 207 138 3553
Notes to Editors
Kanabo is an
Kanabo is currently undertaking a pilot sales scheme to measure key performance indicators in relation to the sale of its non-THC products. It is ready to scale up to meet market demands and projected sales and revenues and to grow the Kanabo brand through its marketing initiatives.
Kanabo's future long-term strategy involves continued research and development activities to develop a range of Unlicensed Medical Cannabis Oils, which will be sold alongside its vaporisation device, the VapePod Medical. It is intended that medicinal products will be sold as unlicensed medicines in the
This information is provided by RNS, the news service of the
Quick facts: Spinnaker Opportunities Plc
Market Cap: -
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...FOR OUR FULL DISCLAIMER CLICK HERE